Literature DB >> 32110153

Phenotypic Variants of Patients with Progressive Supranuclear Palsy.

Murat Gültekın1.   

Abstract

INTRODUCTION: Progressive supranuclear palsy (PSP) is a commonly observed disease among Parkinson plus syndromes, and its early and accurate diagnosis is usually not possible. PSP is currently reported to have eight different subtypes. This study aims to determine the phenotypic subtypes of PSP and reveal their accompanying characteristics.
METHODS: Eighteen patients who were diagnosed as having PSP according to the National Institute for Neurological Disorders and Society for PSP (NINDS-SPSP) criteria were included in the study. Initial symptoms of the patients, their initial diagnosis, course of the disease with time, cranial images, and predominant clinical features were assessed with regard to the subtypes of PSP.
RESULTS: The mean age of the patients was 65.83 years. According to the NINDS-SPSP criteria, all patients were diagnosed as having probable PSP. An evaluation of the patients with respect to the subtypes showed that five different subtypes had predominant characteristics. Richardson's syndrome was found to be the most common subtype.
CONCLUSION: Classifying PSP with regard to its phenotypes may be useful for informing clinicians about the diverse clinical presentations of PSP, thereby possibly improving the diagnostic sensitivity of the disease. Copyright:
© 2020 Turkish Neuropsychiatric Society.

Entities:  

Keywords:  Progressive supranuclear palsy; phenotype; variant

Year:  2017        PMID: 32110153      PMCID: PMC7024825          DOI: 10.5152/npa.2017.22771

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  28 in total

1.  Does corticobasal degeneration exist? A clinicopathological re-evaluation.

Authors:  Helen Ling; Sean S O'Sullivan; Janice L Holton; Tamas Revesz; Luke A Massey; David R Williams; Dominic C Paviour; Andrew J Lees
Journal:  Brain       Date:  2010-07       Impact factor: 13.501

Review 2.  Rational therapeutic approaches to progressive supranuclear palsy.

Authors:  Maria Stamelou; Rohan de Silva; Oscar Arias-Carrión; Evangelia Boura; Matthias Höllerhage; Wolfgang H Oertel; Ulrich Müller; Günter U Höglinger
Journal:  Brain       Date:  2010-05-14       Impact factor: 13.501

3.  Concomitant pathologies among a spectrum of parkinsonian disorders.

Authors:  Brittany N Dugger; Charles H Adler; Holly A Shill; John Caviness; Sandra Jacobson; Erika Driver-Dunckley; Thomas G Beach
Journal:  Parkinsonism Relat Disord       Date:  2014-02-22       Impact factor: 4.891

4.  Primary lateral sclerosis as progressive supranuclear palsy: diagnosis by diffusion tensor imaging.

Authors:  Elizabeth A Coon; Jennifer L Whitwell; Clifford R Jack; Keith A Josephs
Journal:  Mov Disord       Date:  2012-04-19       Impact factor: 10.338

5.  New and reliable MRI diagnosis for progressive supranuclear palsy.

Authors:  H Oba; A Yagishita; H Terada; A J Barkovich; K Kutomi; T Yamauchi; S Furui; T Shimizu; M Uchigata; K Matsumura; M Sonoo; M Sakai; K Takada; A Harasawa; K Takeshita; H Kohtake; H Tanaka; S Suzuki
Journal:  Neurology       Date:  2005-06-28       Impact factor: 9.910

Review 6.  The role of neuroimaging in the diagnosis of the atypical parkinsonian syndromes in clinical practice.

Authors:  Magda Dąbrowska; Michał Schinwelski; Emilia J Sitek; Anna Muraszko-Klaudel; Bogna Brockhuis; Zygmunt Jamrozik; Jarosław Sławek
Journal:  Neurol Neurochir Pol       Date:  2015-10-23       Impact factor: 1.621

7.  Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia.

Authors:  Masato Kanazawa; Mari Tada; Osamu Onodera; Hitoshi Takahashi; Masatoyo Nishizawa; Takayoshi Shimohata
Journal:  Parkinsonism Relat Disord       Date:  2013-08-03       Impact factor: 4.891

8.  Cerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP-C.

Authors:  Shunsuke Koga; Keith A Josephs; Kotaro Ogaki; Catherine Labbé; Ryan J Uitti; Neill Graff-Radford; Jay A van Gerpen; William P Cheshire; Naoya Aoki; Rosa Rademakers; Zbigniew K Wszolek; Owen A Ross; Dennis W Dickson
Journal:  Mov Disord       Date:  2016-02-03       Impact factor: 10.338

9.  Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.

Authors:  Günter U Höglinger; Gesine Respondek; Maria Stamelou; Carolin Kurz; Keith A Josephs; Anthony E Lang; Brit Mollenhauer; Ulrich Müller; Christer Nilsson; Jennifer L Whitwell; Thomas Arzberger; Elisabet Englund; Ellen Gelpi; Armin Giese; David J Irwin; Wassilios G Meissner; Alexander Pantelyat; Alex Rajput; John C van Swieten; Claire Troakes; Angelo Antonini; Kailash P Bhatia; Yvette Bordelon; Yaroslau Compta; Jean-Christophe Corvol; Carlo Colosimo; Dennis W Dickson; Richard Dodel; Leslie Ferguson; Murray Grossman; Jan Kassubek; Florian Krismer; Johannes Levin; Stefan Lorenzl; Huw R Morris; Peter Nestor; Wolfgang H Oertel; Werner Poewe; Gil Rabinovici; James B Rowe; Gerard D Schellenberg; Klaus Seppi; Thilo van Eimeren; Gregor K Wenning; Adam L Boxer; Lawrence I Golbe; Irene Litvan
Journal:  Mov Disord       Date:  2017-05-03       Impact factor: 10.338

10.  Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration.

Authors:  Jonathan D Rohrer; Tammaryn Lashley; Jonathan M Schott; Jane E Warren; Simon Mead; Adrian M Isaacs; Jonathan Beck; John Hardy; Rohan de Silva; Elizabeth Warrington; Claire Troakes; Safa Al-Sarraj; Andrew King; Barbara Borroni; Matthew J Clarkson; Sebastien Ourselin; Janice L Holton; Nick C Fox; Tamas Revesz; Martin N Rossor; Jason D Warren
Journal:  Brain       Date:  2011-09       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.